Advertisement
Screener

AYTU BIOPHARMA, INC (AYTU) Form D

AYTU BIOPHARMA, INC Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2017-05-16: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2017-05-05; Total offering amount Indefinite.
  • 2011-02-04: Federal exemption Rule 505; Types of securities offered Equity; Date of first sale 2010-07-22; Total offering amount Indefinite.
  • 2010-07-22: Federal exemption Rule 505; Types of securities offered Equity; Date of first sale 2010-07-22; Total offering amount $20,000.
  • 2009-04-10: Federal exemption Rule 505; Types of securities offered Equity; Date of first sale 2009-02-06; Total offering amount $25,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2017-05-16Rule 506(b)Equity2017-05-05Indefinite$1,750,000Indefinite16
2011-02-04Rule 505Equity2010-07-22Indefinite$4,000Indefinite1
2010-07-22Rule 505Equity2010-07-22$20,000$10,000$10,0002
2009-04-10Rule 505Equity2009-02-06$25,000$4,500$20,5003

Similar stocks

Stock NameCountryMarket CapPE Ratio
NextCure, Inc. (NXTC)United States$0.024B-0.15
TherapeuticsMD, Inc. (TXMD)United States$0.024B-117.87
ARTELO BIOSCIENCES, INC. (ARTL)United States$0.023B
KYNTRA BIO, INC. (KYNB)United States$0.028B0.17
Transcode Therapeutics, Inc. (RNAZ)United States$0.029B-0.12
Cocrystal Pharma, Inc. (COCP)United States$0.022B
Hepion Pharmaceuticals, Inc. (HEPA)United States$0.029B-0.62
ATOSSA THERAPEUTICS, INC. (ATOS)United States$0.021B-0.52
IGC Pharma, Inc. (IGC)United States$0.029B-5.98
Neuphoria Therapeutics Inc. (NEUP)United States$0.020B-1.77